1 Ginsenoside Re, a major ingredient of Panax ginseng, protects the heart against ischemiareperfusion injury by shortening action potential duration (APD) and thereby prohibiting influx of excessive Ca 2 þ . Ginsenoside Re enhances the slowly activating component of the delayed rectifier K þ current (I Ks ) and suppresses the L-type Ca 2 þ current (I Ca,L ), which may account for APD shortening. 2 We used perforated configuration of patch-clamp technique to define the mechanism of enhancement of I Ks and suppression of I Ca,L by ginsenoside Re in guinea-pig ventricular myocytes. 3 S-Methylisothiourea (SMT, 1 mM), an inhibitor of nitric oxide (NO) synthase (NOS), and N-acetyl-L-cystein (LNAC, 1 mM), an NO scavenger, inhibited I Ks enhancement. Application of an NO donor, sodium nitroprusside (SNP, 1 mM), enhanced I Ks with a magnitude similar to that by a maximum dose (20 mM) of ginseonside Re, and subsequent application of ginsenoside Re failed to enhance I Ks . Conversely, after I Ks had been enhanced by ginsenoside Re (20 mM), subsequently applied SNP failed to further enhance I Ks . 4 An inhibitor of guanylate cyclase, 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ, 10 mM), barely suppressed I Ks enhancement, while a thiol-alkylating reagent, N-ethylmaleimide (NEM, 0.5 mM), clearly suppressed it. A reducing reagent, di-thiothreitol (DTT, 5 mM), reversed both ginsenoside Re-and SNP-induced I Ks enhancement. 5 I Ca,L suppression by ginsenoside Re (3 mM) was abolished by SMT (1 mM) or LNAC (1 mM). NEM (0.5 mM) did not suppress I Ca,L inhibition and DTT (5 mM) did not reverse I Ca,L inhibition, whereas in the presence of ODQ (10 mM), ginsenoside Re (3 mM) failed to suppress I Ca,L . 6 These results indicate that ginsenoside Re-induced I Ks enhancement and I Ca,L suppression involve NO actions. Direct S-nitrosylation of channel protein appears to be the main mechanism for I Ks enhancement, while a cGMP-dependent pathway is responsible for I Ca,L inhibition.